Insider · CIK 0001255856

BAILEY MICHAEL P

Reports to the SEC for 4 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001255856

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	VSTMVerastem, Inc.A Award	Director	AAward	+108K sh	—	—	108,000
2023-01-19	AVEO PHARMACEUTICALS, INC.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−333K sh	$15.00	−$5M	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−275K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−35.3K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−93.5K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−16.8K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−100K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−75.4K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−46K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−90K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−7,499 sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−12K sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−3,249 sh	—	—	0
2023-01-19	AVEO PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−625K sh	—	—	0
2022-12-20	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−26.5K sh	—	—	93,500
2022-12-20	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−85.7K sh	—	—	35,302
2022-12-20	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−165K sh	—	—	625,192
2022-12-20	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+26.5K sh	$6.20	+$164K	82,920
2022-12-20	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+85.7K sh	$5.60	+$480K	175,642
2022-12-20	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+165K sh	$3.67	+$604K	340,167
2022-02-15	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+790K sh	—	—	789,717
2021-09-01	AVEO PHARMACEUTICALS, INC.P Purchase	Director, President & CEO	PPurchase	+15K sh	$6.48	+$97.2K	49,311
2021-02-05	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+275K sh	—	—	275,000
2020-02-05	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.21M sh	—	—	1,210,250
2019-11-21	AVEO PHARMACEUTICALS, INC.P Purchase	Director, President & CEO	PPurchase	+150K sh	$0.60	+$89.6K	318,848
2019-02-06	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.2M sh	—	—	1,200,000
2018-02-01	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1M sh	—	—	1,000,000
2017-06-21	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+189K sh	—	—	188,666
2017-03-28	AVEO PHARMACEUTICALS, INC.J Other	Director, President & CEO	JOther	+100K sh	$0.50	+$50K	168,848
2017-02-08	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+565K sh	—	—	565,000
2016-05-13	AVEO PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+51.8K sh	—	—	68,848
2016-05-13	AVEO PHARMACEUTICALS, INC.Common Stock Warrants (right to buy)A Award	Director, President & CEO	AAward	+51.8K sh	—	—	51,813
2016-01-07	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+460K sh	—	—	460,000
2015-01-07	AVEO PHARMACEUTICALS, INC.S Sale	Director, President & CEO	SSale	−4,484 sh	$0.80	−$3,588.545	17,035
2015-01-06	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+900K sh	—	—	900,000
2015-01-06	AVEO PHARMACEUTICALS, INC.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−13.2K sh	—	—	21,519
2014-01-30	AVEO PHARMACEUTICALS, INC.S Sale	Director, President & CEO	SSale	−5,430 sh	$1.64	−$8,924.205	34,719
2014-01-29	AVEO PHARMACEUTICALS, INC.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−3,200 sh	—	—	40,149
2014-01-29	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Director, President & CEO	AAward	+75K sh	—	—	75,000
2013-10-02	AVEO PHARMACEUTICALS, INC.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−60.7K sh	—	—	43,349
2013-06-26	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Director, President & CEO	AAward	+120K sh	—	—	120,000
2013-06-26	AVEO PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+40K sh	—	—	104,049
2013-01-28	AVEO PHARMACEUTICALS, INC.S Sale	Director, President & CEO	SSale	−767 sh	$7.77	−$5,960.434	64,049
2013-01-24	AVEO PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+42.5K sh	—	—	64,816
2013-01-24	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Director, President & CEO	AAward	+32.5K sh	—	—	32,500
2012-01-31	AVEO PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+18.2K sh	—	—	22,316
2012-01-31	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Director, President & CEO	AAward	+31K sh	—	—	31,000
2012-01-26	AVEO PHARMACEUTICALS, INC.S Sale	Director, President & CEO	SSale	−738 sh	$13.37	−$9,863.96	4,116
2011-02-15	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Director, President & CEO	AAward	+5,000 sh	—	—	5,000
2011-02-15	AVEO PHARMACEUTICALS, INC.A Award	Director, President & CEO	AAward	+4,000 sh	—	—	4,000

Recent filings

Accepted (ET)
May 274
BAILEY MICHAEL P0001104659-26-067048
SEC(opens sec.gov)
Jan 194
BAILEY MICHAEL P0000899243-23-002183
SEC(opens sec.gov)
Dec 224
BAILEY MICHAEL P0001628280-22-032490
SEC(opens sec.gov)

Companies

Address

C/O VERASTEM, INC., 117 KENDRICK ST., SUITE 500

NEEDHAM, MA, 02494